Cargando…

Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry

BACKGROUND: Early reports from the COVID‐19 pandemic identified coronary thrombosis leading to ST‐segment–elevation myocardial infarction (STEMI) as a complication of COVID‐19 infection. However, the epidemiology of STEMI in patients with COVID‐19 is not well characterized. We sought to determine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatt, Ankeet S., Varshney, Anubodh S., Goodrich, Erica L., Gong, Jingyi, Ginder, Curtis, Senman, Balimkiz C., Johnson, Matthew, Butler, Kayleigh, Woolley, Ann E., de Lemos, James A., Morrow, David A., Bohula, Erin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238583/
https://www.ncbi.nlm.nih.gov/pubmed/35470683
http://dx.doi.org/10.1161/JAHA.121.024451
_version_ 1784737088642482176
author Bhatt, Ankeet S.
Varshney, Anubodh S.
Goodrich, Erica L.
Gong, Jingyi
Ginder, Curtis
Senman, Balimkiz C.
Johnson, Matthew
Butler, Kayleigh
Woolley, Ann E.
de Lemos, James A.
Morrow, David A.
Bohula, Erin A.
author_facet Bhatt, Ankeet S.
Varshney, Anubodh S.
Goodrich, Erica L.
Gong, Jingyi
Ginder, Curtis
Senman, Balimkiz C.
Johnson, Matthew
Butler, Kayleigh
Woolley, Ann E.
de Lemos, James A.
Morrow, David A.
Bohula, Erin A.
author_sort Bhatt, Ankeet S.
collection PubMed
description BACKGROUND: Early reports from the COVID‐19 pandemic identified coronary thrombosis leading to ST‐segment–elevation myocardial infarction (STEMI) as a complication of COVID‐19 infection. However, the epidemiology of STEMI in patients with COVID‐19 is not well characterized. We sought to determine the incidence, diagnostic and therapeutic approaches, and outcomes in STEMI patients hospitalized for COVID‐19. METHODS AND RESULTS: Patients with data on presentation ECG and in‐hospital myocardial infarction were identified from January 14, 2020 to November 30, 2020, from 105 sites participating in the American Heart Association COVID‐19 Cardiovascular Disease Registry. Patient characteristics, resource use, and clinical outcomes were summarized and compared based on the presence or absence of STEMI. Among 15 621 COVID‐19 hospitalizations, 54 (0.35%) patients experienced in‐hospital STEMI. Among patients with STEMI, the majority (n=40, 74%) underwent transthoracic echocardiography, but only half (n=27, 50%) underwent coronary angiography. Half of all patients with COVID‐19 and STEMI (n=27, 50%) did not undergo any form of primary reperfusion therapy. Rates of all‐cause shock (47% versus 14%), cardiac arrest (22% versus 4.8%), new heart failure (17% versus 1.4%), and need for new renal replacement therapy (11% versus 4.3%) were multifold higher in patients with STEMI compared with those without STEMI (P<0.050 for all). Rates of in‐hospital death were 41% in patients with STEMI, compared with 16% in those without STEMI (P<0.001). CONCLUSIONS: STEMI in hospitalized patients with COVID‐19 is rare but associated with poor in‐hospital outcomes. Rates of coronary angiography and primary reperfusion were low in this population of patients with STEMI and COVID‐19. Adaptations of systems of care to ensure timely contemporary treatment for this population are needed.
format Online
Article
Text
id pubmed-9238583
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92385832022-06-30 Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry Bhatt, Ankeet S. Varshney, Anubodh S. Goodrich, Erica L. Gong, Jingyi Ginder, Curtis Senman, Balimkiz C. Johnson, Matthew Butler, Kayleigh Woolley, Ann E. de Lemos, James A. Morrow, David A. Bohula, Erin A. J Am Heart Assoc Brief Communication BACKGROUND: Early reports from the COVID‐19 pandemic identified coronary thrombosis leading to ST‐segment–elevation myocardial infarction (STEMI) as a complication of COVID‐19 infection. However, the epidemiology of STEMI in patients with COVID‐19 is not well characterized. We sought to determine the incidence, diagnostic and therapeutic approaches, and outcomes in STEMI patients hospitalized for COVID‐19. METHODS AND RESULTS: Patients with data on presentation ECG and in‐hospital myocardial infarction were identified from January 14, 2020 to November 30, 2020, from 105 sites participating in the American Heart Association COVID‐19 Cardiovascular Disease Registry. Patient characteristics, resource use, and clinical outcomes were summarized and compared based on the presence or absence of STEMI. Among 15 621 COVID‐19 hospitalizations, 54 (0.35%) patients experienced in‐hospital STEMI. Among patients with STEMI, the majority (n=40, 74%) underwent transthoracic echocardiography, but only half (n=27, 50%) underwent coronary angiography. Half of all patients with COVID‐19 and STEMI (n=27, 50%) did not undergo any form of primary reperfusion therapy. Rates of all‐cause shock (47% versus 14%), cardiac arrest (22% versus 4.8%), new heart failure (17% versus 1.4%), and need for new renal replacement therapy (11% versus 4.3%) were multifold higher in patients with STEMI compared with those without STEMI (P<0.050 for all). Rates of in‐hospital death were 41% in patients with STEMI, compared with 16% in those without STEMI (P<0.001). CONCLUSIONS: STEMI in hospitalized patients with COVID‐19 is rare but associated with poor in‐hospital outcomes. Rates of coronary angiography and primary reperfusion were low in this population of patients with STEMI and COVID‐19. Adaptations of systems of care to ensure timely contemporary treatment for this population are needed. John Wiley and Sons Inc. 2022-04-26 /pmc/articles/PMC9238583/ /pubmed/35470683 http://dx.doi.org/10.1161/JAHA.121.024451 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Brief Communication
Bhatt, Ankeet S.
Varshney, Anubodh S.
Goodrich, Erica L.
Gong, Jingyi
Ginder, Curtis
Senman, Balimkiz C.
Johnson, Matthew
Butler, Kayleigh
Woolley, Ann E.
de Lemos, James A.
Morrow, David A.
Bohula, Erin A.
Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry
title Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry
title_full Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry
title_fullStr Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry
title_full_unstemmed Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry
title_short Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry
title_sort epidemiology and management of st‐segment–elevation myocardial infarction in patients with covid‐19: a report from the american heart association covid‐19 cardiovascular disease registry
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238583/
https://www.ncbi.nlm.nih.gov/pubmed/35470683
http://dx.doi.org/10.1161/JAHA.121.024451
work_keys_str_mv AT bhattankeets epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry
AT varshneyanubodhs epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry
AT goodricherical epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry
AT gongjingyi epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry
AT gindercurtis epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry
AT senmanbalimkizc epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry
AT johnsonmatthew epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry
AT butlerkayleigh epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry
AT woolleyanne epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry
AT delemosjamesa epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry
AT morrowdavida epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry
AT bohulaerina epidemiologyandmanagementofstsegmentelevationmyocardialinfarctioninpatientswithcovid19areportfromtheamericanheartassociationcovid19cardiovasculardiseaseregistry